A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.
Journal article published in 2022 by
Lucía Zhu,
Diana Retana,
Sonia Martínez,
Neibla Priego,
Cecilia Sobrino,
Nuria Ajenjo,
Maria‐Jesus Artiga,
P. García Gómez 
,
Eva Ortega‐Paino,
Raúl Torres‐Ruiz,
Sandra Rodríguez‐Perales,
Natalia Yebra,
Riccardo Soffietti,
Luca Bertero,
Lauritz Miarka
and other authors.
,
Eva Ortega‐Paino,
Raúl Torres‐Ruiz,
Sandra Rodríguez‐Perales,
Natalia Yebra,
Riccardo Soffietti,
Luca Bertero,
Lauritz Miarka
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 